APA

Applegate T. L., Birkett D. J., Mcintyre G. J., Jaramillo A. B., Symonds G. & Murray J. M. (20110304). In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy. : Retrovirology.

Chicago

Applegate Tanya Lynn, Birkett Donald John, Mcintyre Glen John, Jaramillo Angel Belisario, Symonds Geoff and Murray John Michael. 20110304. In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy. : Retrovirology.

Harvard

Applegate T. L., Birkett D. J., Mcintyre G. J., Jaramillo A. B., Symonds G. and Murray J. M. (20110304). In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy. : Retrovirology.

MLA

Applegate Tanya Lynn, Birkett Donald John, Mcintyre Glen John, Jaramillo Angel Belisario, Symonds Geoff and Murray John Michael. In silico modeling indicates the development of HIV-1 resistance to multiple shRNA gene therapy differs to standard antiretroviral therapy. : Retrovirology. 20110304.